See more news releases in: Cosmetics and Personal Care, Health Care & Hospitals, Domestic Policy, Foreign Policy & International Affairs, Legal Issues, Product Recalls
GlaxoSmithKline Announces Recall of Poligrip in Japan
Blizzard, McCarthy & Nabers Calls on Company to Follow Suit in U.S.
HOUSTON, March 4 /PRNewswire-USNewswire/ -- Today, the Japanese subsidiary of pharmaceutical giant, GlaxoSmithKline (GSK), announced that it would begin a voluntary recall of Poligrip products that contain zinc in that country Friday. The company's decision followed just three reports of adverse health effects in consumers of the product, sold in Japan as Poligrip EX.
Despite hundreds of American consumers reporting similar disabling effects stemming from the company's many zinc-containing products in the U.S., Glaxo's American subsidiary has yet to order a recall here. Rather, the company seems content to let current stocks of the potentially toxic product sell out, stating that consumers who use the products as directed, "may continue to do so safely."
Attorney Ed Blizzard, of Blizzard, McCarthy & Nabers, which represents a number of clients crippled by Glaxo's Poligrip products, called on the company to act responsibly and issue a similar recall in the United States. "Hundreds of people have reported serious neurological damage associated with this company's products, with potentially thousands more yet to come forward. If Glaxo is concerned enough to recall its products in Japan after only three similar reports, the only appropriate action to take is to follow suit here in America."
On February 18, GSK announced that it would remove zinc from all of its denture adhesive products. That same day, it sent a letter to doctors warning them of the health risks posed by "long-term excessive use" of "zinc-containing denture adhesives Super Poligrip 'Original', Super Poligrip 'Ultra Fresh,' and Super Poligrip 'Extra Care.'" The letter stated that in 2009, the company had "received an increased number of adverse event reports" that together with recent medical literature suggest there are serious dangers associated with the products.
For more information on the dangers associated with zinc and denture adhesive cream, visit www.denturecreamjustice.com.
Blizzard, McCarthy & Nabers, LLP, one of the nation's leading pharmaceutical litigation firms, represents thousands of clients harmed by dangerous drugs and medical devices and has taken on some of the world's largest corporations, including Bristol-Myers, GlaxoSmithKline, Merck, Pfizer and Dow Chemical.
SOURCE Blizzard, McCarthy & Nabers, LLP
Back to top
RELATED LINKS
http://www.denturecreamjustice.com
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
PR Newswire Membership
Fill out a PR Newswire membership form or contact us at (888) 776-0942.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
Featured Video
More in These Categories
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Free Investing Newsletter from Investor Uprising!
Learn to navigate the world's financial system and profit from leading companies.
Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All The Glitters: The Ultimate Gold Report".
- Site Preview
-
Close Site Preview
-
View FullScreen

